Medications offered GLP-1 & GIP* GLP-1* Oral liposomal GLP-1* *Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality
New data ties weight-loss meds to fewer substance harms and sharper questions on cannabis and diabetes GLP-1 weight-loss drugs are changing how people use cannabis and other substances and early data suggest they could affect everything from emergency-room visits to long-term diabetes risk
Accessed 17 Apr 2022 Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W (2012) Obesity and severe obesity forecasts through 2030
Purity and Contamination Most products are sold as research chemicals, not medical-grade therapies
On GLP-1 medications, where appetite suppression can be dramatic, this risk is even more relevant